Consolidated Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Current Assets
Cash and cash equivalents	$ 7,842,667	$ 4,939,955
Investments, held to maturity (net)		6,689,643
Accounts receivable	82,305
Prepaid expenses and other current assets	338,049	869,158
Total Current Assets	8,263,021	12,498,756
Property and Equipment, net	359,592	445,733
Other Assets
Restricted cash	101,171	101,151
Deposits	69,798	69,798
Related party receivable	103,017	58,017
Deferred financing costs		44,307
Total Other Assets	273,986	273,273
Total Assets	8,896,599	13,217,762
Current Liabilities
Accounts payable	290,058	1,980,676
Accrued expenses and other liabilities	1,305,173	1,846,907
Current portion of long term debt		3,133,958
Total Current Liabilities	1,595,231	6,961,541
Long Term Liabilities
Long term debt, net of discount and current portion		3,611,743
Other long term liabilities	461,434	149,748
Total Liabilities	2,056,665	10,723,032
Commitments and Contingencies
Stockholders' Equity
Common stock, $.0002 par value; 50,000,000 shares authorized, 26,204,390 and 8,424,641 issued and outstanding at December 31, 2016 and 2015, respectively	4,926	1,366
Additional paid-in capital	65,868,541	48,566,451
Accumulated deficit	(57,004,655)	(44,430,703)
Accumulated other comprehensive loss	(72,231)	(86,584)
Total Stockholders' Equity - Heat Biologics, Inc	8,796,581	4,050,530
Non-Controlling Interest	(1,956,647)	(1,555,800)
Total Stockholders' Equity	6,839,934	2,494,730
Total Liabilities and Stockholders' Equity	$ 8,896,599	$ 13,217,762

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.